Last Price$2.8(2.8%)
Market Cap$489.8B
25.0%
Peers median - 8.2%
2.1%
Peers median - 6.4%
0.0%
Peers median - 67.5%
(283.7%)
Peers median - 12.0%
Competing with TALK
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$489.8B | 5.3 | $0.0 99.9% overvalued | (4.8%) | $187.6M | $3,855.0K | 25.0% | 2.1% | 45.8% | (283.7%) | 0.0% | |
$78.9B | 6.3 | $368.8 18.5% undervalued | (0.1%) | $70.6B | $5,639.0M | 8.7% | 8.0% | 39.2% | 22.1% | 7.3% | |
$14.6B | 5.5 | $71.8 204.9% undervalued | 28.7% | €19.3B | €2,416.2M | (0.6%) | 12.5% | 24.6% | 3.8% | 69.6% | |
$12.2B | 6.7 | $329.6 130.3% undervalued | 13.8% | $12.8B | $1,470.3M | 5.6% | 11.5% | 48.9% | 11.8% | 544.4% | |
$12.0B | 6.0 | $378.2 203.6% undervalued | 32.9% | $20.7B | $1,116.0M | 0.6% | 5.4% | 35.6% | 10.2% | 154.1% | |
$11.7B | 6.2 | $315.7 79.6% undervalued | 1.0% | $15.8B | $1,123.3M | 10.8% | 7.1% | 51.2% | 15.6% | 73.3% | |
$10.0B | 5.6 | $72.1 27.8% overvalued | 34.3% | $5,373.2M | $280.2M | 11.9% | 5.2% | 29.3% | 11.2% | 12.4% | |
$8,767.7M | 7.0 | $397.3 32.8% overvalued | (6.2%) | $2,431.3M | $368.0M | 7.4% | 15.1% | 50.5% | 23.6% | 12.6% | |
$7,406.8M | 5.6 | $95.8 26.2% overvalued | 3.3% | $4,233.2M | $188.9M | 13.5% | 4.5% | 14.2% | 6.6% | 104.7% | |
$5,760.8M | 6.3 | $24.0 29.4% overvalued | 3.5% | $4,998.2M | $287.8M | 16.2% | 5.8% | 20.0% | 12.2% | 0.0% | |
$2,714.5M | 5.9 | $40.8 39.3% undervalued | (65.8%) | $3,154.0M | ($560.7M) | 7.7% | (17.8%) | 61.1% | 19.6% | 65.3% |
Compare TALK Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Talkspace, Inc.TALK
2,610.6x
25.5%
(76.5%)
(12.8%)
Median Peer Set
1.4x
7.6%
22.3%
7.2%
Acadia Healthcare Company, Inc.ACHC
1.5x
12.2%
N/A
(0.7%)
Chemed CorporationCHE
3.6x
6.1%
8.3%
12.0%
DaVita Inc.DVA
1.8x
5.6%
44.6%
7.3%
Encompass Health CorporationEHC
1.9x
11.9%
28.8%
8.5%
The Ensign Group, Inc.ENSG
2.1x
14.2%
39.9%
7.0%
Fresenius Medical Care AG & Co. KGaAFMS
1.2x
(0.6%)
7.7%
2.8%
HCA Healthcare, Inc.HCA
1.2x
8.7%
15.7%
8.2%
Option Care Health, Inc.OPCH
1.1x
9.1%
79.5%
6.2%
Tenet Healthcare CorporationTHC
1.1x
0.6%
613.3%
15.5%
Universal Health Services, Inc.UHS
1.0x
6.6%
12.1%
5.0%
Compare TALK Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Talkspace, Inc. (TALK) revenue growth compare to peers and the industry?
Talkspace, Inc. (TALK) revenue growth is 25.0%, compared to the peers' median of 8.2%.
2. How does Talkspace, Inc. (TALK) Free Cash Flow (FCF) margin compare to peers and the industry?
Talkspace, Inc. (TALK) FCF margin is 2.1%, compared to the peers' median of 6.4%.
3. How does Talkspace, Inc. (TALK) Total Debt to Equity ratio compare to peers and the industry?
Talkspace, Inc. (TALK) Total Debt to Equity ratio is 0.0%, compared to the peers' median of 67.5%.
4. How does Talkspace, Inc. (TALK) ROIC (Return on Invested Capital) compare to peers and the industry?
Talkspace, Inc. (TALK) ROIC is (283.7%), compared to the peers' median of 12.0%.